Leite de Oliveira, Rodrigo <br/><br/>
Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity.  [electronic resource] 

 -  Cancer cell  Aug 2012 
 - 263-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccr.2012.06.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Antioxidants--metabolism<br/>Basic Helix-Loop-Helix Transcription Factors--metabolism<br/>Cisplatin--adverse effects<br/>Doxorubicin--adverse effects<br/>Gene Targeting<br/>Heart Diseases--chemically induced<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Hypoxia-Inducible Factor-Proline Dioxygenases<br/>Kidney Diseases--chemically induced<br/>Mice<br/>Neoplasms--drug therapy<br/>Organ Specificity--drug effects<br/>Procollagen-Proline Dioxygenase--deficiency